Sarah Kuehne

Publications

  1. 2014
  2. Published

    Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

    Sarah Kuehne, 15 Apr 2014, In : OncoTarget. 5, 7, p. 1761-9 9 p.

    Research output: Contribution to journalArticle

  3. Published
Previous 1 2 3 4 Next